ARTICLE | Clinical News
DSP-1053: Development discontinued
May 19, 2014 7:00 AM UTC
Dainippon Sumitomo disclosed in its earnings for the fiscal year ended March 31 that it discontinued development of DSP-1053, which was in Phase I testing to treat MDD. The company said the compound d...